Early stage, HER2-positive breast cancer patients at increased risk of recurrence
Friday, December 12, 2008 - 15:07
in Health & Medicine
Early-stage breast cancer patients with HER2 positive tumors one centimeter or smaller are at significant risk of recurrence of their disease, compared to those with early-stage disease who do not express the aggressive protein, according to a study led by researchers at The University of Texas M. D. Anderson Cancer Center.
Read the whole article on Physorg
More from Physorg
Related
- Early stage, HER2-positive breast cancer patients at increased risk of recurrenceFri, 12 Dec 2008, 13:15:26 EST
- Early-stage, HER2-positive breast cancer patients at increased risk of recurrenceMon, 2 Nov 2009, 19:10:54 EST
- M. D. Anderson study finds change in HER2 status after treatment with HerceptinThu, 4 Sep 2008, 14:14:57 EDT
- Diet may cut second breast cancers in women without hot flashesTue, 16 Dec 2008, 5:08:27 EST
- HER2 levels may aid in treatment selection for metastatic breast cancerTue, 2 Dec 2008, 10:49:47 EST